Leslie L Trigg - 16 May 2024 Form 4 Insider Report for Outset Medical, Inc. (OM)

Role: Chair and CEO, Director
Signature: By: John L Brottem For: Leslie Trigg
Issuer symbol: OM
Transactions as of: 16 May 2024
Net transactions value: -$18,487
Form type: 4
Filing time: 17 May 2024, 17:25:54 UTC
Previous filing: 26 Feb 2024
Next filing: 31 Jul 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OM	Common Stock	Sale	$18,487	-5,237	-0.57%	$3.53	915,804	16 May 2024	Direct	F1, F2
holding	OM	Common Stock						8,770	16 May 2024	Trigg Family Trust

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 14,739 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021, January 26, 2022, and January 6, 2023. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
F2	Includes 1,801 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of September 1, 2023 to February 29, 2024. This transaction is exempt from Rule 16b-3(c).

Content

Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 14,739 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021, January 26, 2022, and January 6, 2023. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Includes 1,801 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of September 1, 2023 to February 29, 2024. This transaction is exempt from Rule 16b-3(c).